Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary A Ulaner

Showing results (41-50 of 152) with videos related to

Pageof 16
Sort By:
Nuclear Medicine Communications|July 3, 2023
Value of subspecialist second opinion reads of 18 F-FDG PET-CT examinations for patients with breast cancerReza Fardanesh, Kimberly Beavers, Maxine S Jochelson, et al.
PET Clinics|June 3, 2023
Estrogen Receptor-Targeted and Progesterone Receptor-Targeted PET for Patients with Breast CancerGary A Ulaner, Amy M Fowler, Amy S Clark, et al.
PET Clinics|August 14, 2018
Diagnostic Role of Fluorodeoxyglucose PET in Breast Cancer: A History to Current ApplicationDhritiman Chakraborty, Sandip Basu, Gary A Ulaner, et al.
Clinical Nuclear Medicine|July 9, 2019
Focal Immunotherapy-Induced Pancreatitis Mimicking Metastasis on FDG PET/CTJeeban Paul Das, Darragh Halpenny, Richard K Do, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 22, 2018
<sup>18</sup>F-FDG PET/CT for Systemic Staging of Newly Diagnosed Breast Cancer in MenGary A Ulaner, Jessica Juarez, Christopher C Riedl, et al.
Clinical Nuclear Medicine|May 20, 2024
111 In-Pentetreotide-Guided Radiosurgery for Intraoperative Localization of Retroperitoneal Nodal Metastasis in a Patient With Ileal Neuroendocrine TumorMichael J Demeure, Peter Giuliano, Jared Forester, et al.
Clinical Nuclear Medicine|July 26, 2016
Unilateral Suppression of Brown Fat on FDG PET/CT in Horner SyndromeGary A Ulaner, Robert Samstein, Oren Cahlon, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 1, 2017
<sup>18</sup>F-FDG-PET/CT for systemic staging of patients with newly diagnosed ER-positive and HER2-positive breast cancerGary A Ulaner, Raychel Castillo, Jonathan Wills, et al.
Radiology. Imaging Cancer|June 18, 2026
Liver Background Uptake of Prostate-specific Membrane Antigen-targeted PET Radiotracers: A Systematic Review and Meta-AnalysisGary A Ulaner, Ashwin S Parihar, Jeremie Calais, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 19, 2020
Clinical Utility of <sup>18</sup>F-FDG PET/CT for Staging and Treatment Planning in Urachal AdenocarcinomaJeeban P Das, Hebert A Vargas, Soleen Ghafoor, et al.
Pageof 16

Showing results (41-50 of 152) with videos related to

Sort By:
Pageof 16
Nuclear Medicine Communications|July 3, 2023
Value of subspecialist second opinion reads of 18 F-FDG PET-CT examinations for patients with breast cancerReza Fardanesh, Kimberly Beavers, Maxine S Jochelson, et al.
PET Clinics|June 3, 2023
Estrogen Receptor-Targeted and Progesterone Receptor-Targeted PET for Patients with Breast CancerGary A Ulaner, Amy M Fowler, Amy S Clark, et al.
PET Clinics|August 14, 2018
Diagnostic Role of Fluorodeoxyglucose PET in Breast Cancer: A History to Current ApplicationDhritiman Chakraborty, Sandip Basu, Gary A Ulaner, et al.
Clinical Nuclear Medicine|July 9, 2019
Focal Immunotherapy-Induced Pancreatitis Mimicking Metastasis on FDG PET/CTJeeban Paul Das, Darragh Halpenny, Richard K Do, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 22, 2018
<sup>18</sup>F-FDG PET/CT for Systemic Staging of Newly Diagnosed Breast Cancer in MenGary A Ulaner, Jessica Juarez, Christopher C Riedl, et al.
Clinical Nuclear Medicine|May 20, 2024
111 In-Pentetreotide-Guided Radiosurgery for Intraoperative Localization of Retroperitoneal Nodal Metastasis in a Patient With Ileal Neuroendocrine TumorMichael J Demeure, Peter Giuliano, Jared Forester, et al.
Clinical Nuclear Medicine|July 26, 2016
Unilateral Suppression of Brown Fat on FDG PET/CT in Horner SyndromeGary A Ulaner, Robert Samstein, Oren Cahlon, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 1, 2017
<sup>18</sup>F-FDG-PET/CT for systemic staging of patients with newly diagnosed ER-positive and HER2-positive breast cancerGary A Ulaner, Raychel Castillo, Jonathan Wills, et al.
Radiology. Imaging Cancer|June 18, 2026
Liver Background Uptake of Prostate-specific Membrane Antigen-targeted PET Radiotracers: A Systematic Review and Meta-AnalysisGary A Ulaner, Ashwin S Parihar, Jeremie Calais, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 19, 2020
Clinical Utility of <sup>18</sup>F-FDG PET/CT for Staging and Treatment Planning in Urachal AdenocarcinomaJeeban P Das, Hebert A Vargas, Soleen Ghafoor, et al.
Pageof 16